Which anti-thyroid drug?
Published Jun 1, 1986 · David S. Cooper
The American journal of medicine
42
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayMethimazole is recommended for routine management of Graves' disease due to its single daily dose, cheaper cost, and less major toxicity compared to propylthiouracil.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.